Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Publications
Télécharger-
2024Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome., Biochim Biophys Acta Mol Basis Dis 2024 Feb; (): 167097.
-
2024Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future., J Med Virol 2024 Feb; 96(2): e29416.
-
2024Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster., Vaccines (Basel) 2024 Jan; 12(2): .
-
2023Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters., Nat Commun 2023 Jul; 14(1): 4260.
-
2023Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests., Viruses 2023 Feb; 15(3): .
-
2022Primary and Secondary Attack Rates by Vaccination Status after a SARS-CoV-2 B.1.617.2 (Delta) Variant Outbreak at a Youth Summer Camp-Texas, June 2021., J Pediatric Infect Dis Soc 2022 Dec; 11(12): 550-556.
-
2022Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients., Viruses 2022 Sep; 14(9): .
-
2022Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes., Signal Transduct Target Ther 2022 Aug; 7(1): 285.
-
2022Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease., Commun Biol 2022 Aug; 5(1): 805.
-
2022Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)., Lancet Reg Health Am 2022 Jun; 10(): 100216.
-
+Voir la liste complète de publications